XML 57 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Stock Plans and Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option
A summary of stock option activity under the 2010 Plan and Inducement Awards are summarized as follows:
Number of
Options
Weighted
Average
Exercise
Price per
Share
Weighted
Average
Remaining Contractual Life
Aggregate Intrinsic Value
(000's)
Outstanding, December 31, 2023
840,880 $47.58 7.16$91 
Granted518,270 11.39 
Exercised— — 
Canceled(198,899)45.82 
Outstanding, December 31, 2024
1,160,251 $33.44 7.19$— 
Exercisable at December 31, 2024
575,688 $55.36 5.50$— 
Vested and unvested expected to vest at December 31, 2024
1,160,251 $33.44 7.19$— 
Schedule of Valuation Assumptions Used to Calculate Fair Value of Employee Options Awarded the following estimated assumptions under the Black-Scholes option pricing model:
For the Year Ended
December 31,
20242023
Expected term (years)6.05.5
Risk-free interest rate
3.9-4.5%
3.5-4.7%
Expected volatility
114-116%
115-116%
Expected dividend yieldNoneNone
Schedule of Restricted Stock Awards
The following table presents a summary of outstanding RSAs under the 2010 Plan as of December 31, 2024:
Number of
Shares
Weighted
Average
Grant Date Fair Value
Unvested, December 31, 2023
110,500 $18.20 
Awarded— — 
Vested(65,988)18.20 
Forfeited(4,375)18.20 
Unvested, December 31, 2024
40,137 $18.20 
Schedule of Stock-Based Compensation Expense
For the years ended December 31, 2024 and 2023, the Company recorded stock-based compensation expense to the following line items in its costs and expenses section of the Consolidated Statements of Operations and Comprehensive Loss: 
For the Year Ended December 31,
20242023
Research and development expenses$2,760 $2,770 
General and administrative expenses3,167 3,230 
Total stock-based compensation expense$5,927 $6,000